TORONTO, ON / ACCESSWIRE / April 4, 2017 / The Canadian Bioceutical Corporation (the "Company" or "BCC") (CSE: BCC, OTC PINK:
CBICF) today announces that the Company's press release announcing the Massachusetts acquisition, issued this morning, contains an
error in that the sub-heading states the call is on April 4th. The correct date for the call is April 5th. The Company apologizes
for the confusion and looks forward to speaking with investors on the call.
Call details
Date: April 5, 2017
Time: 10am ET
Participants calling from Canada or the United States should call toll-free at: 1-888-231-8191.
Participants calling from the United Kingdom should call toll-free at: 0-800-051-7107.
Callers from other locations may call in at: 1-647-427-7450.
Conference ID: 59653567
It will be possible to follow the cal live via webcast.
Webcast Details
Webcast URL: http://bit.ly/2o3HnPi
The conference call will be archived for replay until Tuesday, April 11, 2017 at midnight. To access the archived conference
call, dial 1-855-859-2056 or 1-416-849-0833 and enter the replay passcode 2520755.
About The Canadian Bioceutical Corporation
BCC, an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides management, staffing, procurement,
advisory, financial, real estate rental, logistics, and administrative services to two medicinal cannabis enterprises in Arizona.
While the Company does not directly own, possess, or sell cannabis or cannabis-infused products, it does provide substantial
support and exerts considerable influence over these two businesses, which are legally authorized to sell medical cannabis and
derivative products. The Company is currently developing a third dispensary in the greater Phoenix Area following the acquisition
of an additional license.
Under the Health for Life ("H4L") brand, the two licensed dispensaries operate in the Mesa area, which is part of the rapidly
growing Phoenix Metropolitan Statistical Area (MSA) with a population of 4.6 million people. Additionally, the Company supports the
Melting Point Extracts ("MPX") brand. The award winning MPX products have facilitated rapid growth of the brand's wholesale
business, now supplying a growing number of Arizona dispensaries.
The Company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been made for a
cannabis production and sales license. In addition, the Company will continue its efforts related to its legacy nutraceuticals
business.
Cautionary Statement Regarding Forward-Looking Information
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation that are not
historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual results,
performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking statements.
Forward-looking statements in this news release include, but are not limited to, the Transaction and BCC's objectives and
intentions. Forward-looking statements are necessarily based on a number of estimates and assumptions that, while considered
reasonable, are subject to known and unknown risks, uncertainties and other factors which may cause actual results and future
events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not
limited to: general business, economic and social uncertainties; litigation, legislative, environmental and other judicial,
regulatory, political and competitive developments; delay or failure to receive board, shareholder or regulatory approvals; those
additional risks set out in BCC's public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news
release. Although BCC believes that the assumptions and factors used in preparing the forward-looking statements are reasonable,
undue reliance should not be placed on these statements, which only apply as of the date of this news release, and no assurance can
be given that such events will occur in the disclosed time frames or at all. Except where required by law, BCC disclaims any
intention or obligation to update or revise any forward-looking statement, whether as a result of new information, future events,
or otherwise.
On behalf of the Board of Directors
The Canadian Bioceutical Corporation
Scott Boyes, CEO
For further information, please contact:
Scott Boyes, President and CEO
The Canadian Bioceutical Corporation info@canadianbioceutical.com www.canadianbioceutocal.com
Marc Lakmaaker NATIONAL Equicom T: +1 416 848 1397 mlakmaaker@national.ca
SOURCE: The Canadian Bioceutical Corporation
